News

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and ...
Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.
AstraZeneca (AZ) has shared positive results from a phase 3b study of its anti-inflammatory reliever rescue therapy Airsupra ...
Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...
In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...
Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...
VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...
Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...
In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...
Johnson & Johnson (J&J) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its ...
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
The US regulator’s decision was supported by results from the phase 3 HELIOS-B trial, in which Alnylam’s drug reduced the risk of all-cause mortality (ACM) and recurrent cardiovascular events by 28% ...